Physician profile
Samuel Bender
NPI 1134159726
$954.78
in general payments reported to CMS, 2019-2025
21 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $57.16 · 2021: $104 · 2022: $103 · 2023: $136 · 2024: $123 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $171.46 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $122.26 | 2025 | Slynd |
| Abbvie INC. | $113.22 | 2021-2023 | Liletta |
| Evofem Biosciences, INC. | $100.03 | 2021-2025 | Phexxi, Solosec, Phexx |
| Biogen, INC. | $62.98 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $50.39 | 2023-2024 | |
| Therapeuticsmd, INC. | $49.21 | 2020-2022 | |
| Duchesnay USA Incorporated | $44.58 | 2019 | |
| Astellas Pharma US INC | $28.10 | 2025 | Veozah |
| Sanofi Pasteur INC. | $25.73 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.16 | 2023 | |
| Shield Therapeutics INC | $23.98 | 2025 | |
| Daiichi Sankyo INC. | $23.92 | 2020 | |
| Agile Therapeutics, INC. | $17.79 | 2022 | |
| Allergan, INC. | $15.88 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $15.49 | 2019 | |
| Covidien Lp | $14.39 | 2019 | |
| Celularity INC. | $14.00 | 2019 | |
| Hologic Sales and Service, LLC | $12.99 | 2019 | |
| Gilead Sciences, INC. | $12.28 | 2019 | |
| Organon LLC | $10.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.